Page last updated: 2024-09-03

1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and mupirocin

1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone has been researched along with mupirocin in 1 studies

Compound Research Comparison

Studies
(1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone)
Trials
(1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone)
Recent Studies (post-2010)
(1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone)
Studies
(mupirocin)
Trials
(mupirocin)
Recent Studies (post-2010) (mupirocin)
7,66601,6581,401214567

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arp, J; Bardl, B; Brakhage, AA; Brock, DA; García-Altares, M; Götze, S; Klapper, M; Mattern, DJ; Mukherji, R; Peschel, G; Queller, DC; Stallforth, P; Strassmann, JE; Willing, K1

Other Studies

1 other study(ies) available for 1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone and mupirocin

ArticleYear
Synergistic activity of cosecreted natural products from amoebae-associated bacteria.
    Proceedings of the National Academy of Sciences of the United States of America, 2018, 04-10, Volume: 115, Issue:15

    Topics: 4-Butyrolactone; Anti-Bacterial Agents; Bacterial Proteins; Biological Products; Dictyostelium; Drug Synergism; Genome, Bacterial; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Pseudomonas; Quorum Sensing; Staphylococcal Infections

2018